CytoDyn Inc.

Pharmaceuticals · VANCOUVER, WA

PharmaceuticalsSEC Form D

CytoDyn Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 11, 2026, reporting $18,600,392 raised.

Incorporated in Delaware and based in VANCOUVER, WA, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that CytoDyn Inc. has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • Jacob P. LalezariExecutive Officer
  • Robert E. HoffmanExecutive Officer
  • Tyler BlokExecutive Officer
  • Lishomwa C. Ndhlovu, M.D., Ph.D.Director
  • Karen J. Brunke, Ph.D.Director
  • Ryan M. DunlapDirector
  • Tanya D. UrbachDirector
  • Stephen M. SimesDirector

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$50.0KRaised

Matthias Therapeutics, LLC

PharmaceuticalsBASKING RIDGE, NJ
May 14, 2026View SEC Form D
$5.3MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 11, 2026View SEC Form D
$2.5MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 8, 2026View SEC Form D
$22.5MRaised

CNS Pharmaceuticals, Inc.

PharmaceuticalsHOUSTON, TX
May 4, 2026View SEC Form D
$4.9MRaised

California Compounding Company, Inc.

PharmaceuticalsLOS ANGELES, CA
May 1, 2026View SEC Form D
CytoDyn Inc. raised $18.6M — SEC Form D